Literature DB >> 24080072

Biomarkers of necrotising enterocolitis.

Pak Cheung Ng1.   

Abstract

Different categories of biomarkers of necrotising enterocolitis (NEC), including (i) non-specific mediators of the inflammatory cascade, e.g. acute phase reactants, chemokines, cytokines, and cell surface antigens, (ii) enhanced non-specific biomarkers, and (iii) specific gut-associated proteins, have distinctive biochemical characteristics and properties. The appropriateness of using these mediators in specific clinical situations, and the pros and cons of their applications as indicators or predictors of intestinal injury and NEC are highlighted. Many potentially new biomarkers such as micro-RNA, volatile organic compounds and gut microbiomes are currently under investigation. A stringent protocol for biomarker discovery is revealed so that investigators can consider this methodology as a reference for future discovery of organ-specific and/or disease-specific biomarkers for preterm infants.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarkers; Infants; Necrotising enterocolitis

Mesh:

Substances:

Year:  2013        PMID: 24080072     DOI: 10.1016/j.siny.2013.09.002

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  7 in total

1.  Targeted inhibition of thrombin attenuates murine neonatal necrotizing enterocolitis.

Authors:  Kopperuncholan Namachivayam; Krishnan MohanKumar; Darla R Shores; Sunil K Jain; Jennifer Fundora; Allen D Everett; Ling He; Hua Pan; Samuel A Wickline; Akhil Maheshwari
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-04       Impact factor: 11.205

Review 2.  Necrotizing enterocolitis: It's not all in the gut.

Authors:  Alissa L Meister; Kim K Doheny; R Alberto Travagli
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-06

Review 3.  Necrotizing enterocolitis: new insights into pathogenesis and mechanisms.

Authors:  Diego F Niño; Chhinder P Sodhi; David J Hackam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

4.  Acylcarnitine Profiles Reflect Metabolic Vulnerability for Necrotizing Enterocolitis in Newborns Born Premature.

Authors:  Karl G Sylvester; Zachary J Kastenberg; R Larry Moss; Gregory M Enns; Tina M Cowan; Gary M Shaw; David K Stevenson; Tiffany J Sinclair; Curt Scharfe; Kelli K Ryckman; Laura L Jelliffe-Pawlowski
Journal:  J Pediatr       Date:  2016-11-08       Impact factor: 4.406

5.  Plasma D-lactate Levels in Necrotizing Enterocolitis in Premature Infants.

Authors:  Guofeng Lei; Junping Zhang; Xiaobing Wang; Meiling Chen
Journal:  Iran J Pediatr       Date:  2016-03-05       Impact factor: 0.364

6.  Association between the p.Thr1406Asn polymorphism of the carbamoyl-phosphate synthetase 1 gene and necrotizing enterocolitis: A prospective multicenter study.

Authors:  Rob M Moonen; Giacomo Cavallaro; Maurice J Huizing; Gema E González-Luis; Fabio Mosca; Eduardo Villamor
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

Review 7.  The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant.

Authors:  Judith Gronbach; Tayyab Shahzad; Sarah Radajewski; Cho-Ming Chao; Saverio Bellusci; Rory E Morty; Tobias Reicherzer; Harald Ehrhardt
Journal:  Stem Cells Int       Date:  2018-04-08       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.